Liver softening spleen reducing capsule

Abstract

A Chinese medicine in the form of capsule for treating hepatocirrhosis, hepatoascites, splenauxe, and transfer from acute to chronic hepatitides is prepared from 4 Chinese medicinal materials including ground beetle, bupleurum root, etc. through proportionally mixing. Its advantages are high curative effect (60% for cure rate and 89% for total effective rate), and low toxic by-effect.

Description

Technical field [0001] The invention relates to a medicine, in particular to a Ruangan Suopi Capsule. Background technique [0002] Liver cirrhosis is a chronic disease that seriously endangers human health. Once the liver function is decompensated, it will cause a series of metabolic disorders, resulting in enlarged spleen and blood coagulation disorder. Currently, there is no effective anti-hepatic fibrosis drug on the market, and Western medicine mostly uses it. Liver protection and supportive therapy cannot effectively prevent the chronic development of hepatitis B. Contents of the invention [0003] The object of the present invention is to provide a Ruangan Suopi Capsule which can effectively treat liver cirrhosis, hepatic ascites and enlarged spleen. [0004] The object of the present invention can be achieved through the following measures: [0005] The medicinal formula of the present invention is: Tuyuan 9-12g, Wenshu 12-15g, Shangjia 12-15g, Bupleurum 9-12g. ...

AI Technical Summary

Problems solved by technology

[0002] Liver cirrhosis is a chronic disease that seriously endangers human health. Once the liver function is decompensated, it will cause a series of metabolic disorders, resulting in enlarged spleen and blood coagulation disorder. Currently, there is no effective anti-hepatic fibrosis drug on the market, and Western medicine mostly uses it. Liver protection and supportive therapy cannot effectively prevent the chronic development of hepatitis B